Cargando…
The cancer glycocode as a family of diagnostic biomarkers, exemplified by tumor-associated gangliosides
One unexploited family of cancer biomarkers comprise glycoproteins, carbohydrates, and glycolipids (the Tumor Glycocode).A class of glycolipid cancer biomarkers, the tumor-marker gangliosides (TMGs) are presented here as potential diagnostics for detecting cancer, especially at early stages, as the...
Autores principales: | Nejatie, Ali, Yee, Samantha S., Jeter, Anna, Saragovi, Horacio Uri |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10637394/ https://www.ncbi.nlm.nih.gov/pubmed/37954075 http://dx.doi.org/10.3389/fonc.2023.1261090 |
Ejemplares similares
-
GD2 and GD3 gangliosides as diagnostic biomarkers for all stages and subtypes of epithelial ovarian cancer
por: Galan, Alba, et al.
Publicado: (2023) -
Mining the “glycocode”—exploring the spatial distribution of glycans in gastrointestinal mucin using force spectroscopy
por: Gunning, A. Patrick, et al.
Publicado: (2013) -
Ligands Binding to Cell Surface Ganglioside GD2 Cause Src-Dependent Activation of N-Methyl-D-Aspartate Receptor Signaling and Changes in Cellular Morphology
por: Tong, Wenyong, et al.
Publicado: (2015) -
Analysis of Staphylococcus aureus wall teichoic acid glycoepitopes by Fourier Transform Infrared Spectroscopy provides novel insights into the staphylococcal glycocode
por: Grunert, Tom, et al.
Publicado: (2018) -
Multiple Myeloma Exemplifies a Model of Cancer Based on Tissue Disruption as the Initiator Event
por: Capp, Jean-Pascal, et al.
Publicado: (2018)